$0.18
4.00% day before yesterday
Nasdaq, May 30, 10:12 pm CET
ISIN
US08862L1035
Symbol
XAIR

Beyond Air Inc Stock price

$0.18
-0.01 6.41% 1M
-0.32 64.04% 6M
-0.18 49.12% YTD
-1.05 85.17% 1Y
-5.57 96.83% 3Y
-6.92 97.43% 5Y
-34.82 99.48% 10Y
Nasdaq, Closing price Fri, May 30 2025
-0.01 4.00%
ISIN
US08862L1035
Symbol
XAIR

Key metrics

Market capitalization $15.75m
Enterprise Value $4.86m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.61
P/S ratio (TTM) P/S ratio 5.22
P/B ratio (TTM) P/B ratio 0.77
Revenue growth (TTM) Revenue growth 337.68%
Revenue (TTM) Revenue $3.02m
EBIT (operating result TTM) EBIT $-50.00m
Free Cash Flow (TTM) Free Cash Flow $-48.30m
Cash position $10.95m
EPS (TTM) EPS $-0.59
P/E forward negative
P/S forward 4.03
EV/Sales forward 1.24
Short interest 3.55%
Show more

Is Beyond Air Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Beyond Air Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Beyond Air Inc forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Beyond Air Inc forecast:

Buy
80%
Hold
20%

Financial data from Beyond Air Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
3.02 3.02
338% 338%
100%
- Direct Costs 5.17 5.17
189% 189%
171%
-2.15 -2.15
172% 172%
-71%
- Selling and Administrative Expenses 29 29
29% 29%
946%
- Research and Development Expense 19 19
15% 15%
639%
-47 -47
25% 25%
-1,556%
- Depreciation and Amortization 3 3
89% 89%
99%
EBIT (Operating Income) EBIT -50 -50
22% 22%
-1,656%
Net Profit -52 -52
22% 22%
-1,732%

In millions USD.

Don't miss a Thing! We will send you all news about Beyond Air Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Beyond Air Inc Stock News

Neutral
GlobeNewsWire
12 days ago
GARDEN CITY, N.Y., May 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that it will report financial results for its fiscal fourth quarter and full year ended March 31, 2025 on Tuesday...
Neutral
GlobeNewsWire
about one month ago
The FDA d esignation m arks a s ignificant m ilestone in the d evelopment of a n ovel t reatment for a r are n eurodevelopmental d isorder
Neutral
GlobeNewsWire
about 2 months ago
Professor Shechtman joins fellow Nobel Prize laureate Professor Roger Kornberg to advance the development of treatments for Autism Spectrum Disorder and Alzheimer's Disease Professor Shechtman joins fellow Nobel Prize laureate Professor Roger Kornberg to advance the development of treatments for Autism Spectrum Disorder and Alzheimer's Disease
More Beyond Air Inc News

Company Profile

Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company. It engages in the developing a nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company develops LungFit platform system, a generator and delivery system that produces nitric oxide from ambient air, eliminating the need for expensive and cumbersome cylinders. Beyond Air was founded in 2011 and is headquartered in Garden City, NY.

Head office United States
CEO Steven Lisi
Employees 107
Founded 2015
Website www.beyondair.net

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today